| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | Director | Common Stock | 11,200 | $305 K | $27.25 | Feb 15, 2024 | Direct |
| PTC THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 10,000 | $271 K | $27.05 | Feb 15, 2024 | Direct |
| Aadi Bioscience, Inc. | Director | Stock Option (right to buy) | 45,832 | Jun 12, 2024 | Direct | ||
| Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25,000 | May 30, 2024 | Direct | ||
| CONSTELLATION PHARMACEUTICALS INC | Chief Financial Officer | Stock Options (Right to buy) | 0 | Jul 15, 2021 | Direct |